The siliq market research report is one of a series of new reports that provides siliq market statistics, including siliq industry global market size, regional shares, competitors with a siliq market share, detailed siliq market segments, market trends and opportunities, and any further data you may need to thrive in the siliq industry. This siliq market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The growth in the forecast period can be attributed to an increasing trend of online shopping among patients, growing patient demand for higher living standards, growing interest in combination therapies, increasing success in clinical trials, and rising telemedicine utilization. Major trends in the forecast period include technological advancements in delivery systems, innovative products and technologies, a shift towards personalized medicine, advanced marketing strategies utilizing digital platforms, and the technological development of AI-based tools.
The increasing prevalence of skin diseases is expected to drive the growth of the Siliq market in the future. Skin diseases encompass a wide range of conditions that affect the skin's appearance, structure, or function, often caused by infections, inflammation, genetic factors, autoimmune disorders, or environmental influences. Contributing factors to the rising prevalence of skin diseases include environmental changes, pollution, increased sun exposure, genetic predispositions, and lifestyle factors such as poor diet and stress. Siliq is particularly effective for treating moderate to severe plaque psoriasis, as it targets specific immune system pathways to reduce inflammation, improve skin appearance, and alleviate symptoms such as redness, scaling, and itching. For example, in January 2024, the American Cancer Society projected 108,270 cases of skin cancer, representing a 3.2% increase from the previous year's 104,930 cases. This rise in skin disease cases contributes to the growth of the Siliq market.
The increasing number of older individuals is expected to further drive demand for Siliq. The geriatric population, typically defined as individuals aged 65 and above, is growing due to longer life expectancy, healthcare advancements, and lower birth rates, resulting in a larger proportion of elderly individuals globally. Siliq is particularly beneficial for the geriatric population as it offers an effective treatment for moderate to severe plaque psoriasis, helping to manage symptoms and improve skin health in older adults, who may face limited treatment options due to age-related health issues. For instance, in July 2024, the UK Parliament's House of Commons Library reported that 12.7 million individuals in the UK were aged 65 and above in 2022, making up 19% of the population. This number is expected to increase to 22.1 million, or 27% of the population, by 2072. The growing geriatric population is expected to drive the demand for Siliq in treating skin conditions such as psoriasis.
An increasing focus on precision medicine is also expected to support the growth of the Siliq market. Precision medicine involves tailoring healthcare treatments based on an individual's genetic, environmental, and lifestyle factors, improving the effectiveness of therapies and minimizing side effects. Advancements in genetic research, the growing understanding of personalized treatments, and the potential for improved patient outcomes have led to a stronger emphasis on precision medicine. Siliq is aligned with precision medicine as it offers a targeted approach to treating moderate to severe plaque psoriasis by inhibiting the IL-17A pathway. This enables personalized and more effective treatment based on individual patient needs. For example, in February 2024, the Personalized Medicine Coalition noted that in 2023, the FDA approved 16 new personalized treatments for rare diseases, compared to just six in 2022. The rising focus on precision medicine is expected to further drive the Siliq market.
The key company operating in the siliq market is Valeant Pharmaceuticals International Inc.
North America was the largest region in the siliq market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in siliq report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the siliq market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Siliq is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Its mechanism of action involves targeting and inhibiting the IL-17A receptor, a pro-inflammatory cytokine that plays a key role in the development of inflammation in conditions such as plaque psoriasis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary clinical indications for Siliq include moderate-to-severe plaque psoriasis and other related conditions. Moderate to severe plaque psoriasis is a chronic skin disorder characterized by red, inflamed patches covered with silvery-white scales. Siliq, a biologic therapy, is specifically designed to treat this condition by targeting and inhibiting the IL-17 receptor, which helps reduce inflammation and plaque formation in affected patients. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and specialty pharmacies, with end users including hospitals, specialty clinics, and home care settings.
The siliq market consists of sales of single-dose prefilled syringes and single-dose prefilled autoinjectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to an increasing trend of online shopping among patients, growing patient demand for higher living standards, growing interest in combination therapies, increasing success in clinical trials, and rising telemedicine utilization. Major trends in the forecast period include technological advancements in delivery systems, innovative products and technologies, a shift towards personalized medicine, advanced marketing strategies utilizing digital platforms, and the technological development of AI-based tools.
The increasing prevalence of skin diseases is expected to drive the growth of the Siliq market in the future. Skin diseases encompass a wide range of conditions that affect the skin's appearance, structure, or function, often caused by infections, inflammation, genetic factors, autoimmune disorders, or environmental influences. Contributing factors to the rising prevalence of skin diseases include environmental changes, pollution, increased sun exposure, genetic predispositions, and lifestyle factors such as poor diet and stress. Siliq is particularly effective for treating moderate to severe plaque psoriasis, as it targets specific immune system pathways to reduce inflammation, improve skin appearance, and alleviate symptoms such as redness, scaling, and itching. For example, in January 2024, the American Cancer Society projected 108,270 cases of skin cancer, representing a 3.2% increase from the previous year's 104,930 cases. This rise in skin disease cases contributes to the growth of the Siliq market.
The increasing number of older individuals is expected to further drive demand for Siliq. The geriatric population, typically defined as individuals aged 65 and above, is growing due to longer life expectancy, healthcare advancements, and lower birth rates, resulting in a larger proportion of elderly individuals globally. Siliq is particularly beneficial for the geriatric population as it offers an effective treatment for moderate to severe plaque psoriasis, helping to manage symptoms and improve skin health in older adults, who may face limited treatment options due to age-related health issues. For instance, in July 2024, the UK Parliament's House of Commons Library reported that 12.7 million individuals in the UK were aged 65 and above in 2022, making up 19% of the population. This number is expected to increase to 22.1 million, or 27% of the population, by 2072. The growing geriatric population is expected to drive the demand for Siliq in treating skin conditions such as psoriasis.
An increasing focus on precision medicine is also expected to support the growth of the Siliq market. Precision medicine involves tailoring healthcare treatments based on an individual's genetic, environmental, and lifestyle factors, improving the effectiveness of therapies and minimizing side effects. Advancements in genetic research, the growing understanding of personalized treatments, and the potential for improved patient outcomes have led to a stronger emphasis on precision medicine. Siliq is aligned with precision medicine as it offers a targeted approach to treating moderate to severe plaque psoriasis by inhibiting the IL-17A pathway. This enables personalized and more effective treatment based on individual patient needs. For example, in February 2024, the Personalized Medicine Coalition noted that in 2023, the FDA approved 16 new personalized treatments for rare diseases, compared to just six in 2022. The rising focus on precision medicine is expected to further drive the Siliq market.
The key company operating in the siliq market is Valeant Pharmaceuticals International Inc.
North America was the largest region in the siliq market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in siliq report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the siliq market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Siliq is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Its mechanism of action involves targeting and inhibiting the IL-17A receptor, a pro-inflammatory cytokine that plays a key role in the development of inflammation in conditions such as plaque psoriasis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary clinical indications for Siliq include moderate-to-severe plaque psoriasis and other related conditions. Moderate to severe plaque psoriasis is a chronic skin disorder characterized by red, inflamed patches covered with silvery-white scales. Siliq, a biologic therapy, is specifically designed to treat this condition by targeting and inhibiting the IL-17 receptor, which helps reduce inflammation and plaque formation in affected patients. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and specialty pharmacies, with end users including hospitals, specialty clinics, and home care settings.
The siliq market consists of sales of single-dose prefilled syringes and single-dose prefilled autoinjectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Siliq Market Characteristics4. Siliq Market Trends And Strategies5. Siliq Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Siliq Pricing Analysis & Forecasts30. Global Siliq Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Siliq Market32. Recent Developments In The Siliq Market
3. Siliq Market Biologic Drug Characteristics
6. Global Siliq Growth Analysis And Strategic Analysis Framework
8. Siliq Market Segmentation
9. Global Siliq Epidemiology Of Clinical Indications
10. Siliq Market Regional And Country Analysis
11. Asia-Pacific Siliq Market
12. China Siliq Market
13. India Siliq Market
14. Japan Siliq Market
15. Australia Siliq Market
16. South Korea Siliq Market
17. Western Europe Siliq Market
18. UK Siliq Market
19. Germany Siliq Market
20. France Siliq Market
21. Eastern Europe Siliq Market
22. North America Siliq Market
23. USA Siliq Market
24. Canada Siliq Market
25. South America Siliq Market
26. Middle East Siliq Market
27. Africa Siliq Market
28. Siliq Market Competitive Landscape And Company Profiles
29. Global Siliq Market Pipeline Analysis
33. Siliq Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Siliq Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on siliq market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for siliq ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The siliq market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Clinical Indication: Moderate To Severe Plaque Psoriasis; Other Indications2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Specialty Pharmacies
3) By End-User: Hospitals; Specialty Clinics; Home Care Settings
Key Companies Profiled: Valeant Pharmaceuticals International Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Valeant Pharmaceuticals International Inc.
